# Unveiling a Novel MT-TS1 m.7479G>A in Mitochondrial Diabetes: The Critical Role of mtDNA Sequencing in Atypical Cases

**Authors:** Eleanor Danek, Felicity Pyrlis, Aleena Shujaat Ali, Elif I Ekinci

PMC · DOI: 10.1210/jcemcr/luaf341 · JCEM Case Reports · 2026-01-28

## TL;DR

A new mitochondrial DNA mutation, MT-TS1 m.7479G>A, is identified as a cause of mitochondrial diabetes in a patient with a strong maternal family history.

## Contribution

The study identifies MT-TS1 m.7479G>A as a novel pathogenic variant in mitochondrial diabetes with low heteroplasmy.

## Key findings

- The MT-TS1 m.7479G>A variant was found in a patient with atypical diabetes and maternal inheritance.
- The patient maintained stable glycemic control without insulin for 21 years.
- Low-heteroplasmy variants may lead to milder mitochondrial diabetes phenotypes.

## Abstract

Mitochondrial diabetes is a rare form of diabetes mellitus caused by mitochondrial DNA (mtDNA) mutations, often presenting with atypical features and maternal inheritance. We report a 71-year-old white female presenting with diabetes diagnosed at age 50, managed with oral therapy, who exhibited significant weight loss and a strong maternal family history of diabetes. Glutamic acid decarboxylase and insulinoma-associated-2 antibodies were negative with normal C-peptide, and genetic testing revealed a heteroplasmic MT-TS1 m.7479G>A variant (13.90%). Glycemic management was achieved with metformin and gliclazide, and at 21 years post diagnosis, the patient maintained stable glycemic control with a glycated hemoglobin A1c of 6.5% (SI: 48 mmol/mol) (reference range, 4.0%-6.0% [SI 20-42 mmol/mol]) without insulin. The MT-TS1 m.7479G>A variant is implicated as a pathogenic cause of mitochondrial diabetes, highlighting the importance of mtDNA sequencing in atypical cases with maternal inheritance, the potential for milder phenotypes with low-heteroplasmy variants, and the critical role of genetic counseling.

## Linked entities

- **Genes:** TRNS1 (tRNA-Ser) [NCBI Gene 4574]
- **Chemicals:** metformin (PubChem CID 4091), gliclazide (PubChem CID 3475)
- **Diseases:** diabetes mellitus (MONDO:0005015), mitochondrial diabetes (MONDO:0010785)

## Full-text entities

- **Genes:** INSM2 (INSM transcriptional repressor 2) [NCBI Gene 84684] {aka IA-6, IA6, mlt1}
- **Diseases:** weight loss (MESH:D015431), diabetes (MESH:D003920), Mitochondrial Diabetes (MESH:C564026)
- **Chemicals:** C-peptide (MESH:D002096), metformin (MESH:D008687), gliclazide (MESH:D005907)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** m.7479G>A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12848932/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12848932/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12848932/full.md

---
Source: https://tomesphere.com/paper/PMC12848932